Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
A deferred prosecution agreement accepted by a federal court Feb. 8 requires a nonprofit North Carolina health system to pay $8 million and comply with the terms of a five-year corporate integrity agreement (CIA) to avoid additional sanctions (United States v. WakeMed , E.D.N.C., No. 5:12-cr-398, agreement approved 2/8/13).
The U.S. District Court for the Eastern District of North Carolina, citing the need to balance the “seriousness of defendant's offense against the potential harm to innocent parties that could result should this prosecution go forward,” concluded that granting the government's request to defer prosecution of WakeMed, d/b/a WakeMed Health and Hospitals, was warranted. Deferring prosecution will allow the system to avoid the threat of exclusion from federal health care programs.
The court reviewed the evidence gathered by the government, and memorialized in a statement of facts included as part of the settlement. The evidence documented a pattern of falsely billing federal programs, including Medicare, between 2003 and 2006, for inpatient care provided to patients at WakeMed's Wake Heart Center in Raleigh, N.C., who were, in fact, treated on an outpatient basis.
The billing of outpatient services as inpatient services occurred in multiple administrative offices but did not jeopardize patient care, the court noted.
In addition to the penalty and five-year CIA, the court noted that other requirements of the agreement that supported approval were a stipulation that the wrongdoing set forth in the statement of facts actually occurred and that WakeMed agreed it was responsible for the actions of its officers, directors, and those in its employ. The court also pointed to the fact that the statement of facts could be used against WakeMed at trial in the event of a breach of the deferred prosecution agreement during the two years the agreement will remain in effect.
It also noted that WakeMed agreed to be monitored under the CIA for five years by an independent review organization that will report to the Department of Health and Human Services. In addition, WakeMed agreed to continue to cooperate with the government through ongoing investigations and to not make public statements contradicting the agreed upon statement of facts, it said.
The agreement also requires the health system to continue the compliance efforts it initiated after the billing problems were first documented by a program integrity contractor in 2007.
According to the court, the deferred prosecution agreement relates to the billing practices for cardiac and other procedures performed at WakeMed only during an unspecified time period. It in no way prevents the government from investigating and prosecuting individuals involved in the false billing or any parties with respect to other fraud or misstatement discovered to have occurred in any other WakeMed facility or department, the court said.
“The Court has also considered the equities at issue, including the impact of defendant's actions on the primary victims in this matter--the Medicare program and the taxpayers who contribute to it. Such consideration must also include, however, the protection of defendant's employees and healthcare providers who are blameless but who would suffer severe consequences should defendant be convicted and debarred as a Medicare and Medicaid provider,” the court said.
“Moreover, the Court has considered the threat that the provision of essential healthcare to WakeMed's patients would be interrupted and that the needs of the underprivileged in the surrounding area would be drastically and inhumanely curtailed should defendant be forced to close its doors as a result of the instant prosecution,” the court said.
The agreement calls for dismissal of the criminal action if, after the two-year period has elapsed, the health system has complied with all of its obligations and has engaged in no additional criminal conduct.
WakeMed was represented by Maureen D. Murray, with Smith Moore Leatherwood LLP, Greensboro, N.C., and Stephen W. Petersen, with Smith Moore Leatherwood LLP in Raleigh, N.C. The government was represented by William M. Gilmore, with the U.S. Attorney's Office in Raleigh.
By Peyton M. Sturges
The court's decision approving the settlement is athttp://www.bloomberglaw.com/public/document/USA_v_WakeMed_Docket_No_512cr00398_EDNC_Dec_19_2012_Court_Docket. The deferred prosecution agreement is at http://op.bna.com/hl.nsf/r?Open=psts-94tsxd. The statement of facts is at http://op.bna.com/hl.nsf/r?Open=psts-94tsxe. A civil settlement agreement is at http://op.bna.com/hl.nsf/r?Open=psts-94tsxf. The corporate integrity agreement is at http://op.bna.com/hl.nsf/r?Open=psts-94tsxg.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)